Referenzen
1. Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. Empfehlungen zur intensivmedizinischen therapie von patienten mit COVID-19. Medizinische Klinik-Intensivmedizin und Notfallmedizin. 2020;1–3.
2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: Summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA.
3. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in wuhan, china: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020.
4. Organization WH et al. Clinical management of severe acute respiratory infection when novel coronavirus ( nCoV) infection is suspected: Interim guidance, 25 january 2020. World Health Organization; 2020.
5. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet. 2020.
6. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the united states. New England Journal of Medicine. 2020.
7. Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science. 2020.
8. Organization WH et al. Novel coronavirus ( 2019-nCoV): Situation report, 12. 2020.
9. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. The Lancet. 2020.
10. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in wuhan, china, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020.
11. Organization WH et al. Report of the who-china joint mission on coronavirus disease 2019 (covid-19). Available on-line: https://www who int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report pdf. 2020.
12. Kompetenz SA der et al. Hinweise zu erkennung, diagnostik und therapie von patienten mit COVID-19. 2020.
13. Team TNCPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — china, 2020. China CDC Weekly. 2020;2:113. http://weekly.chinacdc.cn//article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51.
14. Berking M. Training emotionaler kompetenzen. 2017.
15. Casajuana J, Iglesias B, Fàbregas M, Fina F, Vallès J-A, Aragonès R, et al. Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: A single blinded multi-centre randomized controlled clinical trial. BMC Hematology. 2008;8:1.
16. Reducing pain at the time of vaccination: WHO position paper, September 2015Recommendations. Vaccine. 2016;34:3629–30. doi:10.1016/j.vaccine.2015.11.005.
17. Friederichs H, Birkenstein R, Becker J, Marschall B, Weissenstein A. Risk literacy assessment of general practitioners and medical students using the berlin numeracy test. 2019.
18. Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, et al. School closure and management practices during coronavirus outbreaks including COVID-19: A rapid systematic review. The Lancet Child & Adolescent Health. 2020.